Statement Of Cash Flows [Abstract]

Heidelberg Pharma AG - Filing #6821989

Concept 2020-12-01 to
2021-11-30
As at
2021-11-30
2019-12-01 to
2020-11-30
As at
2020-11-30
As at
2019-11-30
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
26.583.865 EUR
17.879.048 EUR
Cash flows from (used in) operating activities
26.612.520 EUR
17.892.611 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities
0 EUR
198 EUR
Purchase of property, plant and equipment, classified as investing activities
1.242.138 EUR
1.368.396 EUR
Proceeds from sales of intangible assets, classified as investing activities
0 EUR
4 EUR
Purchase of intangible assets, classified as investing activities
147 EUR
66 EUR
Cash flows from (used in) investing activities
1.401.953 EUR
1.289.794 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
20.006.742 EUR
14.386.901 EUR
Payments of lease liabilities, classified as financing activities
102 EUR
94 EUR
Cash flows from (used in) financing activities
29.169.662 EUR
14.290.458 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
4 EUR
9 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
1.159.218 EUR
4.901.360 EUR
Cash and cash equivalents
6.141.451 EUR
4.982.232 EUR
9.883.592 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.